Journal profile · Pathology
Pathology
ISSN 0031-3025 · eISSN 1465-3931 · Lippincott Williams and Wilkins Ltd. · AUSTRALIA · Quarterly · Founded 1969
Pathology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.65; hybrid open access; APC about USD 3,600; median 128 days to acceptance (103 articles, last 24 months); community-reported acceptance: fairly easy; 560 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pathology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment and Clinical Laboratory Practices and Quality Control, together about 20.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Large volumes of polyethylene glycol (PEG) solution reduce patient acceptance of colonoscopy. A prepackaged low-residue diet (PLRD; Clear-Through) may improve bowel cleansing and allow further PEG reduction. This exploratory randomized study evaluated whether PLRD permits decreased PEG with ascorbic acid (PEG-Asc) volume while maintaining cleansing quality.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Brett DelahuntPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine8.3%
- Lymphoma Diagnosis and TreatmentMedicine6.7%
- Clinical Laboratory Practices and Quality ControlMedicine5.4%
- Cancer and Skin LesionsMedicine5%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology4.7%
- Soft tissue tumor case studiesMedicine4.3%
- Chronic Lymphocytic Leukemia ResearchMedicine4.1%
- Ovarian cancer diagnosis and treatmentMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.65LetPub ·
- Impact factor (publisher)
- 2.97Publisher website ·
- CiteScore 2026-06
- 5LetPub ·
- SJR 2026-06
- 0.94LetPub ·
- SNIP 2026-06
- 1.22LetPub ·
- h-index
- 57LetPub ·
- h-index
- 127OpenAlex ·
- i10-index
- 3,155OpenAlex ·
- 2-year mean citedness
- 0.57OpenAlex ·
- Self-citation rate
- 2.6%LetPub ·
- Share of gold OA articles
- 18.41%LetPub ·
Volume
- Articles per year
- 96LetPub ·
Articles by year OpenAlex count · 16,222 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 448 | 49 | 17 |
| 2025 | 560 | 55 | 253 |
| 2024 | 562 | 490 | 622 |
| 2023 | 513 | 390 | 1,067 |
| 2022 | 451 | 82 | 1,311 |
| 2021 | 379 | 185 | 1,839 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
128 daysMedian, submission to acceptance · P25–P75 93 days – 178 days
- Acceptance to online
- median 69 days (103 articles)
- Submission to online
- median 203 days
- Sample
- 103 articles with submission and acceptance dates (349 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,600 / EUR 3,370 / GBP 2,880 / JPY 446,510 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- AUSTRALIA
- Language
- English
- Frequency
- Quarterly
- Founded
- 1969
- ISSN
- 0031-3025
- Electronic ISSN
- 1465-3931
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Pathology
What CAS zone is Pathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pathology is in Zone 3 of Medicine, and in Zone 3 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pathology?
The latest impact factor listed by LetPub is 3.65; CiteScore 5, h-index 127.
How long does peer review take at Pathology?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 128 days (interquartile range 93–178 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Pathology?
According to LetPub and DOAJ records, Pathology is indexed in SCIE and Scopus.
Is Pathology open access, and what is the APC?
Pathology is a hybrid journal. For open-access publication: APC about USD 3,600.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .